RX-1 Rhythm Express Remote Cardiac Monitoring System vs FibriCheck

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
VS
by FibriCheck

AI Verdict

Both tools offer AI-powered remote cardiac monitoring for arrhythmia detection. The RX-1 Rhythm Express provides continuous, multi-mode ECG monitoring via a dedicated wearable patch, making it suitable for detailed clinical diagnostics and extended monitoring periods. FibriCheck, conversely, leverages a smartphone camera for intermittent PPG-based heart rhythm checks, offering a more accessible and patient-centric option for screening and self-monitoring.

Choose RX-1 Rhythm Express Remote Cardiac Monitoring System if…

Choose the RX-1 Rhythm Express if your patient requires continuous, high-fidelity ECG monitoring over several days for comprehensive arrhythmia diagnosis and characterization. This system is ideal for situations demanding superior noise suppression and near real-time data transmission to a physician for detailed review, such as Mobile Cardiac Telemetry or extended Holter studies.

View RX-1 Rhythm Express Remote Cardiac Monitoring System →

Choose FibriCheck if…

Choose FibriCheck if your patient needs a convenient, accessible tool for regular self-monitoring of heart rhythm using their smartphone. This app is best suited for patients who can actively participate in their monitoring, providing immediate insights into potential arrhythmias like AFib, and for healthcare providers seeking a simple way to track patient heart rhythm trends between clinic visits.

View FibriCheck →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature RX-1 Rhythm Express Remote Cardiac Monitoring System FibriCheck
Pricing Available Subscription-based, with options for monthly or annual payments. prices vary by region and may be partly or fully covered by insurance or employer.
Deployment Cloud-based Cloud-based (private cloud).
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

RX-1 Rhythm Express Remote Cardiac Monitoring System

Tool A, the RX-1 Rhythm Express, is a patch-style wearable device offering continuous monitoring for up to 5 days, which provides a 'set it and forget it' experience for patients. This passive, continuous monitoring approach is generally more convenient and less intrusive for extended periods compared to Tool B's requirement for active engagement with a smartphone camera for each measurement.

Clinical Value

RX-1 Rhythm Express Remote Cardiac Monitoring System

Tool A offers continuous 2-channel ECG monitoring across MCT, Event, and Holter modes, which is considered the gold standard for cardiac rhythm assessment and provides comprehensive diagnostic data. Its proprietary MDSPu2122 technology for superior noise suppression further enhances the accuracy and reliability of the clinical data. While Tool B is medically certified and detects arrhythmias via PPG, ECG provides a higher level of diagnostic detail and clinical utility.

Pricing & Value

FibriCheck

Tool B, FibriCheck, provides transparent and specific pricing for both end-users and short-term doctor-prescribed use, making costs clear upfront. While Tool A offers flexible enterprise-focused billing models, the lack of specific pricing details makes it difficult to assess its direct value proposition without further inquiry. Tool B's clear pricing and potentially lower entry cost for patients offer a more immediate understanding of value.

Enterprise Readiness

RX-1 Rhythm Express Remote Cardiac Monitoring System

Both tools are FDA-cleared and HIPAA compliant, establishing a baseline for enterprise use. However, Tool A explicitly states BAA availability and offers multiple clinic-focused billing models (subscription, fee-for-service, split-bill), indicating a strong design for integration into existing clinical workflows and revenue cycles. Its comprehensive monitoring modes also cater to a broader range of clinical diagnostic needs.

Innovation

RX-1 Rhythm Express Remote Cardiac Monitoring System

Tool A's proprietary Multi-Domain Signal Processing (MDSPu2122) technology for superior noise suppression in ECG signals represents a significant innovation in improving the fundamental quality and reliability of cardiac diagnostic data. While Tool B innovatively leverages smartphone camera technology for accessibility, Tool A's advancement directly addresses a core technical challenge in accurate ECG measurement.

Support & Docs

FibriCheck

FibriCheck (Tool B) provides a readily discoverable online Help Center with FAQs and user guides, offering structured support resources for its users. In contrast, a quick web search for VivaQuant RX-1 (Tool A) did not immediately reveal a dedicated, easily accessible support or documentation portal beyond general contact information.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature RX-1 Rhythm Express Remote Cardiac Monitoring System FibriCheck
Name RX-1 Rhythm Express Remote Cardiac Monitoring System FibriCheck
Company VivaQuant Qompium nv
Description An FDA-cleared, patch-style wearable device offering continuous ECG monitoring in MCT, Event, and Holter modes. It utilizes proprietary MDSP™ technology for superior noise suppression and accurate arrhythmia detection, providing near real-time data transmission to a cloud platform for physician review. A medically certified app that helps patients monitor their heart rhythm to detect and monitor arrhythmias using just their smartphone.
Key Monitoring Technology Continuous 2-channel ECG monitoring with proprietary Multi-Domain Signal Processing (MDSP™) technology Smartphone camera-based PPG technology for heart rhythm measurement
Specialties Cardiology Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring RX-1 Rhythm Express Remote Cardiac Monitoring System and FibriCheck.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The RX-1 Rhythm Express uses a patch-style wearable device for continuous 2-channel ECG monitoring, leveraging proprietary MDSPu2122 technology for noise suppression and AI for arrhythmia detection. FibriCheck utilizes a smartphone camera-based photoplethysmography (PPG) technology combined with an AI-powered algorithm to detect and analyze heart rhythms.
The RX-1 Rhythm Express provides continuous 2-channel ECG monitoring in Mobile Cardiac Telemetry (MCT), Event Recorder (ER), and Wireless Holter (WH) modes, with an extended battery life of up to 5 days on a single charge. FibriCheck offers smartphone-based heart rhythm measurements, which are typically patient-initiated 60-second measurements, though healthcare providers can set customizable monitoring rules.
The RX-1 Rhythm Express, with its 2-channel ECG and MDSPu2122 technology, offers high-clarity ECG recording and is considered diagnostic-grade for detailed cardiac information and arrhythmia detection. While PPG is suitable for monitoring heart rate during daily activities, ECG is generally considered the gold standard for heart rate and rhythm assessment and is preferable for clinical diagnostics and detailed cardiac assessments. FibriCheck's PPG performance has demonstrated equivalence to single-lead ECG for AF detection.
The RX-1 Rhythm Express emphasizes superior noise suppression, continuous 2-channel ECG, and built-in cellular connectivity for near real-time data transmission to a cloud platform for physician review. FibriCheck allows patients to log blood pressure and weight, offers customizable monitoring rules for healthcare providers, and provides a professional portal/dashboard for patient monitoring and access to clinical reports.
AI Tool Finder
AI-powered search. Results may not be comprehensive.